MediciNova (MNOV)
MediciNova Market Cap: 27.84M
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
Select a metric
Date range:
to
<Embed Chart>
Pro Save as Image
Pro Data Export
Copy the code below and paste
into the embed destination.
into the embed destination.
Attention
OK
MNOV Market Cap Rankings
| Overall | 8th percentile | 4254 of 4664 |
| Sector | 11th percentile | 464 of 527 in Healthcare |
| Industry | 8th percentile | 150 of 164 in Biotechnology |
MNOV Market Cap Range, Past 5 Years
| Minimum | 19.05M | Dec 2008 |
| Maximum | 97.46M | Jun 2007 |
| Average | 53.44M |
About Market Capitalization
Market Capitalization (Market Cap) is a measurement of business value based on share price and number of shares outstanding. It generally represents the market's view of a company's stock value and is a determining factor in stock valuation.
For example, if a company has 1.5 million shares outstanding at a share price of $25, its market cap is $37.5 million (1.5 million x $25). Companies can be categorized based upon the size of their market capitalization.
There are five basic groups: mega-cap (market cap over $200B), large-cap ($10B–$200B), mid-cap ($2B–$10B), small-cap ($300M–$2B), and micro-cap ($50M-$300M). Market cap is not always an accurate indication of value because it does not account for debt and other factors.
Learn More
You may also be interested in these MNOV related companies
MNOV News
$MNOV Anyone think this is a good buying opportunity? it's is 1.66 A.H.
about 6 days ago by SomeGuy900
about 6 days ago by SomeGuy900
$MNOV Up 9%, good day for MNOV. The bio part of my portfolio has been a dream lately. ARNA!
about 21 days ago by chesty1
about 21 days ago by chesty1
MediciNova Receives Notice of an Australian Patent Allowance for a Method of Treating Neuropathic Pain
Apr 23, 7:00PM GlobeNewswire
Apr 23, 7:00PM GlobeNewswire
MediciNova Management to Host a Conference Call to Discuss 2011 Earnings Thursday, March 29th at 5:00 P.M. (EDT)
Mar 22, 7:00PM GlobeNewswire
Mar 22, 7:00PM GlobeNewswire
MediciNova (MNOV) Gets Notice of Allowance in Japan for MN-166 Patent Application
Mar 13, 6:02PM Street Insider
Mar 13, 6:02PM Street Insider
MediciNova Receives Notice of a Japanese Patent Allowance for a Method of Treating Neuropathic Pain
Mar 13, 6:00PM GlobeNewswire
Mar 13, 6:00PM GlobeNewswire
MediciNova to Present at American Academy of Emergency Medicine Annual Meeting
Feb 08, 4:30PM GlobeNewswire
Feb 08, 4:30PM GlobeNewswire
MediciNova (MNOV) Receives Notice of Allowance for MS-Treatment Ibudilast Patent
Feb 01, 6:40AM Street Insider
Feb 01, 6:40AM Street Insider
MediciNova Receives a Notice of Patent Allowance for a Method of Treating Progressive Multiple Sclerosis
Feb 01, 6:00AM GlobeNewswire
Feb 01, 6:00AM GlobeNewswire
MediciNova and University of Colorado Boulder Collaborate on Potential Novel Therapy for Traumatic Brain Injury
Jan 16, 6:00AM GlobeNewswire
Jan 16, 6:00AM GlobeNewswire
$MNOV $2.52 Mkt Cap $38,446,971 registering $15,000,000 for sale from time to time (39% dilution)
about 391 days ago by canarionyc
about 391 days ago by canarionyc
$mnov XPRT Was over a 1.80$ just 2 weeks ago now at Just 14 Cents a share this thing is way oversold bottom of the chart huge move up coming
about 452 days ago by StockPro
about 452 days ago by StockPro
Brian Hunt's Market Notes: NEW HIGHS OF NOTE LAST WEEK - $HLXW.OB $IMGN $MNOV $RDEA $SCLN $SGP $NDN $LQD - http://tinyurl.com/mvn9fd
about 1053 days ago by TheDailyCrux
about 1053 days ago by TheDailyCrux
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| MNOV | 1.73 | -0.01 | -0.75% | 27.84M |
| MNKD | 1.83 | -0.01 | -0.54% | 306.47M |
| MNI | 2.19 | -0.02 | -0.91% | 187.05M |
| MNE | 15.25 | +0.14 | +0.89% | |
| MNDO | 1.70 | -0.01 | -0.58% | 31.84M |
| MKTX | 32.33 | -0.11 | -0.34% | 1.164B |
| MKTG | 10.34 | -0.01 | -0.10% | 490.53M |
| MKTAY | 33.29 | -0.83 | -2.43% | 4.549B |
| MKSI | 26.17 | -0.26 | -0.98% | 1.375B |
| MKL | 434.25 | -1.00 | -0.23% | 4.191B |
